MRI Enhancement in Stromal Tissue Surrounding Breast Tumors: Association with Recurrence Free Survival following Neoadjuvant Chemotherapy

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Jones, Ella F ^a   Sinha, Sumedha P ^a   Newitt, David C ^a   Klifa, Catherine ^a   Kornak, John ^a   Park, Catherine C ^a   Hylton, Nola M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST; BREAST STROMA; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER GRADING; CONTRAST ENHANCEMENT; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCENT ENHANCEMENT; QUANTITATIVE ANALYSIS; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SIGNAL ENHANCEMENT RATIO; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; SIGNAL-TO-NOISE RATIO;

EID: 84877128293     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061969     Document Type: Article

References (25)

1. Guidi A, Schnitt S, Fischer L, Tognazzi K, Harris J, et al. (1997) Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer 80: 1945-1953.
2. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature 420: 860-867.
3. Tlsty TD, Hein PW, (2001) Know thy neighbor: stromal cells can contribute oncogenic signals. Current opinion in genetics & development 11: 54-59.
4. Griffiths L, Dachs GU, Bicknell R, Harris AL, Stratford IJ, (1997) The Influence of Oxygen Tension and pH on the Expression of Platelet-derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Human Breast Tumor Cells Grown in Vitro and in Vivo. Cancer Research 57: 570-572.
5. Beck AH, Sangoi AR, Leung S, Marinelli RJ, Nielsen TO, et al. (2011) Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Science translational medicine 3: 108ra113.
6. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, et al. (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nature medicine 14: 518-527.
7. Hattangadi J, Park C, Rembert J, Klifa C, Hwang J, et al. (2008) Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy. AJR American journal of roentgenology 190: 1630-1636.
8. Klifa C, Carballido-Gamio J, Wilmes L, Laprie A, Lobo C, et al. (2004) Quantification of breast tissue index from MR data using fuzzy clustering. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Conference 3: 1667-1670.
9. Nabavizadeh N, Klifa C, Newitt D, Lu Y, Chen YY, et al. (2011) Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI. Integrative biology: quantitative biosciences from nano to macro 3: 490-496.
10. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, et al. (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR American journal of roentgenology 179: 1193-1199.
11. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Tripathy D, et al. (2005) MRI Measurements of Breast Tumor Volume Predict Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival. American Journal of Roentgenology 184: 1774-1781.
12. (2008) ACR Practice Guideline for the Performance of Contrast Enhanced Magnetic Resonance Imging (MRI) of the Breast. American College of Radiology.
13. Hylton NM (1999) Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magnetic resonance imaging clinics of North America 7: 411-420, x.
14. Li K-L, Partridge SC, Joe BN, Gibbs JE, Lu Y, et al. (2008) Invasive Breast Cancer: Predicting Disease Recurrence by Using High-Spatial-Resolution Signal Enhancement Ratio Imaging1. Radiology 248: 79-87.
15. Partridge SC, Heumann EJ, Hylton NM, (1999) Semi-automated analysis for MRI of breast tumors. Studies in health technology and informatics 62: 259-260.
16. Roskelley CD, Williams DE, McHardy LM, Leong KG, Troussard A, et al. (2001) Inhibition of Tumor Cell Invasion and Angiogenesis by Motuporamines. Cancer Research 61: 6788-6794.
17. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, et al. (2002) Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nature genetics 32: 355-357.
18. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ, (1998) Mammographic densities and breast cancer risk. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 7: 1133-1144.
19. Li T, Sun L, Miller N, Nicklee T, Woo J, et al. (2005) The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 14: 343-349.
20. Graham SJ, Ness S, Hamilton BS, Bronskill MJ, (1997) Magnetic resonance properties of ex vivo breast tissue at 1.5 T. Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine/ Society of Magnetic Resonance in Medicine. 38: 669-677.
21. Li SP, Makris A, Beresford MJ, Taylor NJ, Ah-See M-LW, et al. (2011) Use of Dynamic Contrast-enhanced MR Imaging to Predict Survival in Patients with Primary Breast Cancer Undergoing Neoadjuvant Chemotherapy. Radiology 260: 68-78.
22. Hylton N, (2006) Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 24: 3293-3298.
23. Gray RJ, (1992) Flexible Methods for Analyzing Survival Data Using Splines, With Applications to Breast Cancer Prognosis. Journal of the American Statistical Association 87: 942-951.
24. Singer L, Wilmes LJ, Saritas EU, Shankaranarayanan A, Proctor E, et al. (2012) High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer. Academic radiology 19: 526-534.
25. Partridge SC, Ziadloo A, Murthy R, White SW, Peacock S, et al. (2010) Diffusion tensor MRI: preliminary anisotropy measures and mapping of breast tumors. Journal of magnetic resonance imaging: JMRI 31: 339-347.